[68Ga]Ga-FAPI-04 PET/MR与[18F]FDG PET/CT在T分期≤2a2子宫颈癌患者中诊断价值的比较:一项前瞻性研究
前瞻性纳入25例病理确诊且T分期≤T2a2的子宫颈癌患者,均在2周内完成全身[68Ga]Ga-FAPI-04 PET/MR与[18F]FDG PET/CT,PET后10天内接受手术。两种方法对原发肿瘤阳性检出率均为96.0%,[68Ga]Ga-FAPI-04 PET/MR诊断淋巴结转移的特异度100%(95%CI 84.6%~100.0%)显著高于[18F]FDG PET/CT的59.1%(95%CI 36.4%~79.3%)(p=0.004)。
要点
- 两种方法对原发肿瘤阳性检出率均为96.0%,T分期准确率分别为50%和55.0%。
- [68Ga]Ga-FAPI-04 PET/MR淋巴结转移特异度100%,显著高于[18F]FDG PET/CT的59.1%(p=0.004)。
- [68Ga]Ga-FAPI-04 PET/MR有潜力用于更准确的治疗计划,从而明确早期年轻患者的生育力保留指征。
核心结论
- [68Ga]Ga-FAPI-04 PET/MR与[18F]FDG PET/CT对子宫颈癌原发肿瘤的检测能力相当,但[68Ga]Ga-FAPI-04 PET/MR对淋巴结转移的诊断价值显著高于[18F]FDG PET/CT,有潜力用于更准确的治疗计划并明确早期年轻患者的生育力保留指征。
研究设计与样本
- 前瞻性纳入病理确诊且T分期≤T2a2的子宫颈癌患者25例,所有患者均在2周内完成全身[68Ga]Ga-FAPI-04 PET/MR与[18F]FDG PET/CT,PET后10天内接受手术治疗。
主要发现
- 20例患者行根治性子宫切除术(均行盆腔淋巴结清扫,其中10例行腹主动脉旁淋巴结清扫),3例仅行腹腔镜淋巴结清扫未行子宫切除术,2例因[18F]FDG与[68Ga]Ga-FAPI-04均显示淋巴结高代谢而被分期为FIGO IIIC1r并接受同步放化疗(CCRT)。[18F]FDG与[68Ga]Ga-FAPI-04对原发肿瘤阳性检出率均为96.0%,T分期准确率分别为50%和55.0%,分期升高和低估均源于阴道浸润或肿瘤大小的误判。
关键数值与推荐
- [68Ga]Ga-FAPI-04诊断淋巴结转移的特异度为100%(95%CI 84.6%~100.0%),显著高于[18F]FDG的59.1%(95%CI 36.4%~79.3%)(p=0.004)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To compare the diagnostic value of [68 Ga]Ga-FAPI-04 PET/MR and [18F]FDG PET/CT in patients with T stage ≤ 2a2 uterine cervical cancer patients. METHODS: Patients pathologically diagnosed with cervical cancer and with a T stage ≤ T2a2 were prospectively enrolled. All patients underwent whole-body [68 Ga]Ga-FAPI-04 PET/MR and [18F]FDG PET/CT within 2 weeks, and surgical treatment was performed within 10 days after PET. RESULTS: Twenty-five patients were enrolled. Twenty patients underwent radical hysterectomy, among which all of them underwent pelvic lymphadenectomy, and 10 patients underwent para-aortic lymphadenectomy. Three patients received merely laparoscopic lymphadenectomy without hysterectomy. Two patients with both [18F]FDG and [68 Ga]Ga-FAPI-04 lymph node high metabolism were staged as FIGO IIIC1r, and concurrent chemoradiation therapy (CCRT) was performed. [18F]FDG and [68 Ga]Ga-FAPI-04 had equivalent detection ability on primary tumors, with a positive detection rate of 96.0%. The accuracy of T staging using [18F]FDG and [68 Ga]Ga-FAPI-04 was relatively 50% and 55.0%. Elevated and underrated staging was due to misdiagnosis of either vaginal infiltration or tumor size. In terms of lymph node metastasis detection, the specificity of [68 Ga]Ga-FAPI-04 was 100% (95% CI, 84.6% ~ 100.0%), which was significantly higher than [18F]FDG (59.1% (95% CI, 36.4% ~ 79.3%)) (p = 0.004). CONCLUSION: [68 Ga]Ga-FAPI-04 PET/MR and [18F]FDG PET/CT demonstrated an equivalent detection ability on cervical cancer primary tumors. However, [68 Ga]Ga-FAPI-04 PET/MR's diagnostic value in lymph node metastasis was significantly higher than [18F]FDG PET/CT. [68 Ga]Ga-FAPI-04 PET/MR has the potential for more accurate treatment planning, thus clarifying fertility preservation indications for early-stage young patients.
引用
- Lyu Y, Chen X, Liu H, et al. Comparison of the diagnostic value of [68 Ga]Ga-FAPI-04 PET/MR and [18F]FDG PET/CT in patients with T stage ≤ 2a2 uterine cervical cancer: a prospective study. Eur J Nucl Med Mol Imaging. 2023. PMID: 38032383. doi:10.1007/s00259-023-06539-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。